Publications by authors named "Federica Campomori"

Article Synopsis
  • Long-term treatment of rheumatoid arthritis with tumor necrosis factor-α inhibitors can show early changes in disease activity that help predict treatment responses later on.
  • The study monitored 1,598 patients over 48 months, comparing the effectiveness of original biologics (adalimumab and etanercept) with their biosimilars.
  • Results indicate no significant difference in effectiveness between the original drugs and their biosimilars, with all treatments showing reduced disease activity levels that continued for up to 48 months.
View Article and Find Full Text PDF

Objective: The term scleroderma pattern typically defines capillary abnormalities of scleroderma spectrum disorders, mainly systemic sclerosis (SSc) and dermatomyositis (DM). Our study aimed to investigate differences in nailfold videocapillaroscopy (NVC) between DM and SSc, with a cross-sectional and longitudinal evaluation.

Methods: NVC features of 29 consecutive patients with DM were compared with 90 patients with SSc categorized into the 3 subsets of scleroderma pattern: early, active, and late.

View Article and Find Full Text PDF

Background: Microvascular involvement plays a decisive role in systemic sclerosis (SSc) pathogenesis occurring early in the course of the disease. Microangiopathy is responsible of important clinical manifestations, such as Raynaud's phenomenon, digital ulceration, and pulmonary arterial hypertension. Typical microvascular alterations, called scleroderma pattern, are detectable at nailfold capillaroscopy in a significant percentage of SSc patients; however its prevalence is highly variable in published studies.

View Article and Find Full Text PDF

Vasculitis is a heterogeneous group of disorders characterized by the presence of necrotic inflammatory phenomena and destruction of blood vessels. Vasculitis is classified as primary (idiopathic) or secondary to infections, connective tissue diseases and drugs but can also be considered as a paraneoplastic phenomenon. Evidence shows that the increasing use of biological agents results in a growing number of reports of autoimmune diseases induced by these therapies.

View Article and Find Full Text PDF